查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861923

生物技術儀器市場按設備類型、技術、應用、最終用戶和銷售管道分類 - 全球預測 2025-2032

Biotechnology Instrumentation Market by Instrument Type, Technology, Application, End User, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物技術測量設備市場將成長至 575 億美元，複合年成長率為 10.17%。

關鍵市場統計數據
基準年 2024 264.9億美元
預計年份：2025年 292.4億美元
預測年份 2032 575億美元
複合年成長率 (%) 10.17%

本文清楚概述了影響生物技術生態系中實驗室採購行為和設備價值提案的各項因素。

生物技術儀器產業正處於十字路口，技術創新、不斷變化的監管要求以及不斷變化的全球供應鏈正在推動實驗室營運和商業策略的重塑。產業相關人員日益關注能夠加速發現並縮短可靠數據獲取時間的系統，而儀器供應商則透過模組化平台、整合軟體和服務導向經營模式來應對這一需求。隨著實驗室對更高通量和可重複性的需求不斷成長，儀器正從獨立硬體轉向融合本地運算、雲端分析和遠距離診斷的網路化生態系統。

本文概述了影響儀器產業採購優先事項和產品藍圖的關鍵因​​素。文章全面分析了正在重新定義終端用戶價值的趨勢，涵蓋了從學術研究機構到大型製藥企業研發部​​門的各個層面，包括生命週期支援、整合耗材和運作保障。文章也檢驗了競爭格局，指出能夠提供經過驗證的工作流程、無縫軟體整合和擴充性維護服務的公司將更具優勢。總而言之，這些趨勢既為製造商帶來了短期營運挑戰，也帶來了中期機遇，因此需要透過與生命週期服務、數位化和實驗室現代化舉措相契合的策略夥伴關係關係來實現差異化。

在本報告中，我們提供了將產品創新與商業策略聯繫起來的分析，使決策者能夠調整其設備投資，以滿足科學家、實驗室管理人員和採購負責人不斷變化的期望。

數位化、單細胞創新和服務導向商業模式如何改變產品設計和供應商差異化

過去十年發生的變革正在重塑設備的構思、採購和使用方式。首先，數位化已從邊緣走向核心，內建軟體和分析技術將硬體轉變為資料工廠。如今，衡量設備的標準不僅在於其光學或機械性能，還在於其數據管道和API生態系統。因此，提供開放式、可互通架構的供應商正在贏得市場，從而實現下游自動化和跨平台工作流程。

其次，以樣本為中心的分析方法，例如單細胞分析和空間生物學，推動了對能夠大規模捕捉複雜數據的儀器的需求。這促進了小型化、多重分析能力和高靈敏度檢測器的發展，而自動化和機器人技術的興起則推動了對通量和標準化的關注，進而促使人們投資於整合樣本處理和檢驗的工作流程。

第三，商業模式正轉向基於結果的服務和訂閱模式，這使用戶能夠降低採購風險，並為供應商帶來持續收入。這些模式通常包含遠距離診斷和預測性維護，從而減少非計劃性停機時間和營運摩擦。最後，永續性和監管審查正在影響產品設計和供應鏈，製造商正在採用環保材料和可追溯性功能，以滿足機構採購要求和合規性。

這些變化共同造就了這樣一種格局：敏捷性、軟體能力和服務品質決定了市場領導地位。

評估 2025 年關稅變化如何重塑籌資策略和計劃，加速供應商多元化和區域化。

2025年，貿易政策趨勢為全球供應鏈帶來了新的摩擦，迫使測量設備製造商和實驗室營運商重新評估其籌資策略和成本結構。關鍵零件和組件的關稅調整增加了進口模組的到岸成本，尤其是那些依賴精密光學元件、專用電子元件和某些耗材的設備。這種直接影響使得供應鏈韌性成為重中之重，各公司紛紛加快供應商多元化、選擇二級供應商，並在某些情況下採取近岸組裝策略，以降低跨境關稅風險。

隨著採購方式的改變，採購週期也在延長，因為採購負責人和財務團隊要求提高整體擁有成本 (TCO) 的透明度。潛在的關稅波動以及與海關合規相關的行政成本現在經常被納入資本配置的考慮範圍。為了保持競爭力，許多供應商正在重組材料清單(BOM)，用貿易壁壘較低的同等產品替代關稅風險較高的零件，同時投資於本地認證並擴大服務範圍，以消除買家的顧慮。

在營運方面，研發機構正透過延長設備檢驗週期，並集中採購大型平台供應商的產品來應對，這些供應商能夠提供捆綁式保固和本地服務，從而降低運作中斷的風險。儘管貿易夥伴和產業協會之間的監管對話未來可能緩解貿易摩擦，但在短期內，關稅的累積效應正在推動成本透明化、供應商多元化以及區域製造地的重組，以保障關鍵實驗室的正常運作。

透過深度細分分析，將設備類型、進階功能、應用優先順序、終端用戶趨勢和通路連結起來，從而指導可行的商業策略。

要了解市場，需要詳細了解儀器類型、技術模式、應用案例、最終用戶和通路，因為這些因素都會影響產品需求和商業性優先順序。按儀器類型分類，市場涵蓋層析法、顯微鏡、PCR 和光譜分析。層析法可細分為快速液相層析 (FPLC)、氣相層析法和高效能液相層析 (HPLC)。顯微鏡分為共聚焦顯微鏡、電子顯微鏡和螢光顯微鏡。 PCR 分為數位 PCR (dPCR) 和定量 PCR (qPCR) 兩種形式，光譜分析包括質譜、核磁共振 (NMR) 和紫外-可見光光譜系統。依技術分類，流式細胞技術、免疫檢測、微陣列和定序是核心技術。流式細胞技術進一步分為細胞計數和細胞分選功能，免疫分析區分化學發光免疫分析 (CLIA) 和酶聯免疫檢測(ELISA) 平台，微陣列區分 DNA 和蛋白質特異性陣列，定序區分次世代定序和桑格測序方法。

應用細分明確了診斷、藥物發現、基因組學和蛋白​​質組學領域的最終用戶優先事項。診斷分為臨床診斷和就地檢驗；藥物發現分為先導藥物最適化和標靶識別；基因組學分為基因表現和突變分析；蛋白質體學分為蛋白質定量和交互作用研究。最終用戶細分反映了學術研究機構、生物技術公司、臨床實驗室、受託研究機構(CRO) 和製藥公司之間採購趨勢的差異。生技公司分為大型企業和中小企業，製藥公司也分為大型企業和中小企業。最後，銷售管道細分突顯了直銷、分銷商、電商和零售通路的作用，並進一步根據系統整合商和增值轉售商來定義分銷模式。

這些相互交織的細分市場揭示了產品設計必須與工作流程整合相契合的領域、服務和耗材策略如何影響客戶維繫，以及通路選擇如何影響產品被接受的時間。例如，用於製藥實驗室的超靈敏光譜系統需要完善的服務網路和檢驗的工作流程，而面向學術研究人員的定序平台則受益於模組化定價和開放的軟體生態系統。認知這些細微差別，供應商就能最佳化其市場進入策略，確定研發重點，並建立能體現各細分市場獨特經濟效益的夥伴關係。

區域趨勢將影響需求模式、合規要求和服務模式。

區域特徵顯著影響儀器應用模式、監管合規性以及服務生態系的結構。美洲地區聚集了大量大型製藥企業總部、轉化研究中心和臨床實驗室網路，從而對高性能儀器和綜合服務合約產生了持續的需求。該地區重視快速檢驗週期和強大的供應商支援網路，這促使供應商配備現場維修設施和認證的現場工程師，以最大限度地減少停機時間並加速儀器應用。

在歐洲、中東和非洲地區，嚴格的法規結構以及強調可重複性和永續性的資金籌措模式正在影響採購決策。這促使買家優先考慮那些擁有完善合規文件、更長生命週期支援以及採用環保材料的設備。在該地區營運的供應商必須應對各種不同的報銷和採購法規，同時也要維持互通性標準，以支援跨國研究聯盟。

亞太地區匯聚了許多先進的研究中心和蓬勃發展的診斷網路，多個市場優先發展本土製造和創新。基因組學和生物製藥研發領域的大量投資正在推動該地區的成長，但服務成熟度和監管路徑卻存在差異。因此，供應商正透過靈活的商業模式取得成功，這些模式結合了本地生產和組裝、與本地服務供應商建立能力建設夥伴關係，以及為提升實驗室人員技能而量身定做的培訓計畫。

所有地區通用的共同挑戰包括：強大的數位化賦能、可擴展的服務營運以及監管合規。能夠使商業條款與當地採購慣例相符並建立本地支援的供應商，在客戶滿意度和實施速度方面往往優於競爭對手。

整合平台策略、服務品質和生態系統協作如何驅動測量設備產業的競爭優勢和客戶維繫

在計量領域，競爭優勢日益依賴卓越的硬體效能，並結合整合的軟體、耗材和全生命週期服務。主要企業透過投資檢驗的工作流程來脫穎而出，這些工作流程能夠縮短從安裝到獲得可操作結果的時間；此外，他們還開發軟體平台，以實現資料標準化、遠端監控和預測性維護。與試劑和耗材供應商的合作，透過鎖定工作流程和實驗室人員認證計劃，能夠提高經常性收入並增強客戶留存率。

新興競爭對手正專注於小眾創新，以取代特定應用場景下的傳統系統，例如超高通量樣品製備模組、緊湊型質譜儀和人工智慧驅動的影像分析引擎。這些挑戰者正利用其敏捷性和針對性投資來滿足尚未滿足的需求，例如單細胞分析、空間生物學和快速診斷。儀器製造商與第三方軟體供應商之間的策略合作正變得日益普遍，這有助於實現互通性，並加快整合應用的成果交付速度。

從商業性角度來看，能夠透過全面的服務協議、透明的耗材定價和完善的培訓計畫顯著降低營運摩擦的公司，將獲得進入機構採購管道的優先權。此外，制定符合監管趨勢和永續性目標的藍圖的公司，將增強買家信心，並開拓與公共部門採購和大型製藥企業合作的機會。總而言之，市場領導將技術實力與可擴展的服務產品和生態系統夥伴關係相結合，以在競爭激烈的環境中保持成長並保障利潤率。

對供應商而言，策略要務在於推動建立具有韌性的供應鏈、模組化創新以及以客戶為中心的商業模式，從而降低採用門檻。

領導企業應優先考慮兼顧三大支柱的策略：產品創新、供應鏈韌性和以顧客為中心的商業模式。首先，投資於模組化硬體架構和開放軟體生態系統，能夠實現產品快速整合到各種實驗室工作流程中。此類設計可縮短客製化時間，便於第三方整合，並支援迭代式功能升級，而無需更換硬體。注重互通性使供應商能夠實現更廣泛的應用，同時支援協作式研究環境。

其次，我們將透過對多家零件供應商進行資格認證、尋求區域製造夥伴關係以及為關鍵產品線維持策略性零件庫存，來強化我們的供應鏈策略。這些措施將降低我們受關稅波動的影響，並縮短替換零件和耗材的前置作業時間。同時，我們將擴展遠距離診斷和預測性維護能力，從而減少成本高昂的現場維護，並提高大型終端用戶的設備運轉率指標。

第三，發展能夠使獎勵與客戶利益一致的商業模式，例如按績效付費合約、按需訂閱服務以及結合現場支援和遠端分析的混合服務協議。同時，輔以全面的培訓和認證項目，降低採用門檻，建立長期客戶忠誠度。此外，加強與本地服務供應商和學術機構的夥伴關係，以提升本地市場滲透率，並確保快速回應的技術支援。

綜合來看，這些措施使供應商能夠抓住策略機遇，同時降低營運風險，使其在技術領先地位和可信賴的商業性合作方面都佔據優勢。

採用嚴謹的混合方法研究，結合實務工作者訪談、技術綜合和專家檢驗，以產生情境化的策略洞見。

本研究採用混合方法，結合一手質性訪談、二手文獻綜述和專家檢驗，以確保獲得可靠的實務見解。一手資料包括對來自學術機構、生物技術公司、臨床實驗室和製藥公司的設備經理、採購人員和研發人員進行結構化訪談，以收集關於其營運挑戰、採購標準和服務期望的第一手資訊。這些定性見解與對同行評審文獻、技術白皮書、監管指導文件和供應商技術規範的廣泛審查進行三角驗證，以檢驗產品特性和實施注意事項。

分析方法包括對訪談記錄進行主題編碼以識別優先事項，對不同儀器類別的產品功能集進行比較評估，以及專注於供應鍊和監管影響的情境分析。區域比較利用人口統計和製度指標來分析採用趨勢。專家對研究結果進行反覆審查，以完善結論並使建議與實驗室操作人員和採購部門面臨的實際限制一致。

本研究的局限性包括各機構採購慣例的差異以及貿易政策和監管指導的不斷變化。為彌補這些局限性，調查方法強調跨部門檢驗，並尋求多方相關人員的佐證，從而增強了報告中提出的策略見解的可信度。

策略摘要闡述了平台適應性、服務深度和供應商韌性，認為這些是實現持續部署和實驗室連續性的基礎。

總之，生物技術設備產業正向整合、服務型平台轉型，這些平台同等重視硬體效能和數位生態系統。實驗室互通性、可維護性和可預測的服務模式的要求日益提高，而供應商則必須在創新、供應鏈韌性和區域監管要求之間取得平衡。近期貿易政策調整的累積影響加速了供應商多元化和在地化生產的趨勢，進一步凸顯了在採購討論中採用透明的、總成本分析方法的必要性。

細分市場分析表明，成功的關鍵在於根據特定模式需求和最終用戶工作流程調整產品藍圖，這適用於從高通量藥物研發環境到資源受限的學術實驗室等各種場景。區域性打入市場策略至關重要，它需要將本地服務能力與可擴展的數位化支援相結合。競爭優勢將來自於檢驗的工作流程、經濟高效的耗材以及能夠減少操作摩擦並實現可重複性科學研究的軟體平台。

對於整個生態系中的相關人員，挑戰顯而易見：投資於適應性強的平台，深化服務能力，並尋求能夠加速產品普及的策略夥伴關係，同時保障營運的連續性。能夠優先執行這些策略的公司將更有利於抓住市場需求，並與推動科學進步的研究機構保持長期合作關係。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合微流體實驗室晶片平台用於快速照護現場和個人化醫療
  • 透過採用人工智慧驅動的高通量篩檢系統來加速藥物發現流程
  • 單細胞定序儀器的發展使得深入了解細胞異質性成為可能
  • 可攜式奈米孔定序設備的出現將加速基因組分析在偏遠地區的普及。
  • 利用基於 CRISPR 的電化學生物感測器在食品安全應用中進行病原體即時檢測
  • 在生物製藥實驗室中推廣應用自動化液體處理機器人，以簡化重複性的樣品製備工作流程
  • 引入無標定表面等離子體共振成像技術進行多重生物標記定量分析
  • 開發用於空間蛋白質體學應用的整合質譜成像系統
  • 學術實驗室對用於高解析度代謝體學分析的桌上型核磁共振波譜系統的需求日益成長
  • 數位PCR平台技術的進步提高了腫瘤診斷中罕見等位基因檢測的敏感度。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 生物技術測量設備市場（依設備類型分類）

  • 層析法
    • FPLC
    • 氣相層析法
    • HPLC
  • 顯微鏡
    • 共聚焦顯微鏡
    • 電子顯微鏡
    • 螢光顯微鏡
  • PCR
    • dPCR
    • qPCR
  • 光譜學
    • 質譜分析
    • 核磁共振波譜
    • 紫外-可見光譜

第9章 生技儀器市場（依技術分類）

  • 流式細胞技術
    • 細胞計數
    • 細胞分選
  • 免疫檢測
    • CLIA
    • ELISA
  • 微陣列
    • DNA微陣列
    • 蛋白質微陣列
  • 定序
    • 次世代定序
    • 桑格定序

第10章 生技儀器市場（依應用領域分類）

  • 診斷
    • 臨床診斷
    • 就地檢驗
  • 藥物發現
    • 先導藥物最適化
    • 目標識別
  • 基因組學
    • 基因表現
    • 變異分析
  • 蛋白質體學
    • 蛋白質定量
    • 蛋白質-蛋白質相互作用

第11章 生技儀器市場（依最終用戶分類）

  • 學術研究
  • 生技公司
    • 大型生技公司
    • 小型生技公司
  • 臨床實驗室
  • CRO（受託研究機構）
  • 製藥公司
    • 大型製藥企業
    • 中小型製藥公司

第12章 生物技術測量儀器市場（依銷售管道分類）

  • 直銷
  • 經銷商
    • 系統整合商
    • 增值轉售商
  • 線上銷售
  • 零售通路

第13章 生技儀器市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 生技儀器市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國生技儀器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • Roche Diagnostics GmbH
    • Waters Corporation
    • Bruker Corporation
    • Shimadzu Corporation
Product Code: MRR-521BAA36EA70

The Biotechnology Instrumentation Market is projected to grow by USD 57.50 billion at a CAGR of 10.17% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 26.49 billion
Estimated Year [2025] USD 29.24 billion
Forecast Year [2032] USD 57.50 billion
CAGR (%) 10.17%

A clear overview of the forces redefining laboratory purchasing behavior and instrumentation value propositions across the biotechnology ecosystem

The biotechnology instrumentation landscape sits at a crossroads where technological innovation, evolving regulatory expectations, and shifting global supply chains converge to reshape laboratory operations and commercial strategies. Industry stakeholders increasingly prioritize systems that accelerate discovery while reducing time to reliable data, and instrumentation suppliers are responding with modular platforms, integrated software, and service-oriented business models. As laboratories demand higher throughput and reproducibility, instruments are migrating from standalone hardware toward networked ecosystems that embed local compute, cloud analytics, and remote diagnostics.

This introduction outlines the critical forces influencing procurement priorities and product road maps within instrumentation. It synthesizes how end users-from academic research centers to large pharmaceutical R&D groups-are redefining value to include lifecycle support, integrated consumables, and guaranteed uptime. It also frames the competitive dynamics that favor firms able to deliver validated workflows, seamless software integrations, and scalable maintenance offerings. Taken together, these trends create both near-term operational challenges and medium-term opportunities for manufacturers to differentiate through lifecycle services, digital enablement, and strategic partnerships that align with laboratory modernization initiatives.

Throughout the report, readers will find analyses that connect product innovation with commercial strategies, enabling decision-makers to align investments in instrumentation with the evolving expectations of scientists, lab managers, and procurement officers.

How digitization, single-cell innovation, and service-oriented commercial models are collectively reshaping product design and vendor differentiation

The last decade has delivered transformative shifts that alter how instruments are conceived, purchased, and consumed. First, digitization has moved from peripheral to central, with embedded software and analytics transforming raw hardware into data factories. Instruments are now judged as much by their data pipelines and API ecosystems as by their optical or mechanical performance. Consequently, vendors who offer open, interoperable architectures gain traction, as they enable downstream automation and cross-platform workflows.

Second, sample-centric approaches such as single-cell analysis and spatial biology have driven demand for instruments that can capture complexity at scale. This has incentivized miniaturization, multiplexing capabilities, and higher sensitivity detectors. Meanwhile, the rise of automation and robotics has made throughput and standardization critical, prompting investment in integrated sample handling and validated workflows.

Third, commercial models are shifting toward outcome-based services and subscription frameworks that de-risk procurement for users while creating recurring revenue for suppliers. These models are often bundled with remote diagnostics and predictive maintenance, which reduce unplanned downtime and operational friction. Last, sustainability and regulatory scrutiny are influencing product design and supply chains, with manufacturers incorporating greener materials and traceability features to meet institutional purchasing mandates and compliance requirements.

Together, these shifts create a landscape where agility, software competence, and service excellence determine market leadership.

Evaluating how 2025 tariff changes have realigned sourcing strategies and procurement timelines while prompting accelerated supplier diversification and regionalization

In 2025, trade policy developments introduced additional friction into global supply chains, prompting instrument manufacturers and laboratory operators to reassess sourcing strategies and cost structures. Tariff adjustments on key components and assemblies have raised landed costs for certain imported modules, especially for instruments that rely on precision optics, specialized electronics, and certain consumable components. The immediate consequence has been a prioritization of supply chain resilience, with firms accelerating strategies to diversify suppliers, qualify secondary sources, and in some cases nearshore assembly to mitigate exposure to cross-border duties.

Parallel to sourcing changes, procurement timelines have lengthened as procurement officials and finance teams require greater transparency on total cost of ownership. Capital allocation now frequently factors in potential duty volatility and the administrative overhead associated with customs compliance. To preserve competitiveness, many vendors are reconfiguring bills of materials to substitute tariff-exposed parts with equivalent components that carry lower trade barriers, while simultaneously investing in local certifications and service footprints to reassure buyers.

Operationally, R&D organizations have responded by extending equipment validation cycles and by consolidating purchases to larger platform vendors who can offer bundled warranties and on-site service that reduce the risk of interruptions. Over time, regulatory dialogues between trading partners and industry consortia may ease transactional frictions, but in the near term the cumulative effect of tariffs has incentivized cost transparency, supplier diversification, and a renewed emphasis on regional manufacturing footprints to protect critical laboratory operations.

Deep segmentation analysis linking instrument types, advanced modalities, application priorities, end-user dynamics, and distribution pathways to actionable commercial strategies

Understanding the market requires a granular view of instrument types, technology modalities, use cases, end users, and distribution pathways because each axis informs product requirements and commercial priorities. Instrument Type segmentation spans Chromatography, Microscopy, PCR, and Spectroscopy, with Chromatography further differentiated into FPLC, Gas Chromatography, and HPLC; Microscopy subdivided into Confocal, Electron, and Fluorescence platforms; PCR categorized into dPCR and qPCR formats; and Spectroscopy encompassing Mass Spectrometry, NMR, and UV-Vis systems. Technology segmentation identifies Flow Cytometry, Immunoassays, Microarrays, and Sequencing as core modalities, where Flow Cytometry further bifurcates into cell counting and cell sorting capabilities, Immunoassays distinguishes CLIA and ELISA platforms, Microarrays separate DNA and protein-focused arrays, and Sequencing contrasts next-generation and Sanger approaches.

Application segmentation clarifies end-use priorities across Diagnostics, Drug Discovery, Genomics, and Proteomics, with Diagnostics delineated into clinical diagnosis and point-of-care testing, Drug Discovery separated into lead optimization and target identification, Genomics parsed into gene expression and variant analysis, and Proteomics into protein quantification and interaction studies. End User segmentation captures distinct purchasing dynamics across Academic Research, Biotechnology Companies, Clinical Laboratories, Contract Research Organizations, and Pharmaceutical entities, noting that Biotechnology Companies split into large and small biotech while Pharmaceutical customers differentiate between large and small pharma. Finally, Sales Channel segmentation highlights the role of direct-sales, distributors, online commerce, and retail channels, with distributor models further defined by systems integrators and value-added resellers.

These intersecting segmentations reveal where product design must align with workflow integration, where service and consumable strategies will influence retention, and where channel selection impacts time-to-deployment. For example, high-sensitivity spectroscopy systems destined for pharmaceutical labs require deep service networks and validated workflows, while sequencing platforms aimed at academic researchers benefit from modular pricing and open software ecosystems. Recognizing these nuances helps vendors tailor go-to-market strategies, prioritize R&D, and structure partnerships that reflect the distinct economics of each segment.

Regional dynamics shaping demand patterns, compliance requirements, and service models across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics materially influence instrument adoption patterns, regulatory compliance, and the structure of service ecosystems. The Americas continue to host a concentration of large pharmaceutical headquarters, translational research centers, and clinical laboratory networks, creating sustained demand for high-performance instrumentation and integrated service contracts. This region emphasizes rapid validation cycles and strong vendor support networks, which in turn incentivize suppliers to maintain local repair facilities and certified field engineers to minimize downtime and accelerate adoption.

In Europe, Middle East & Africa, procurement decisions are often shaped by a combination of stringent regulatory frameworks and funding models that reward reproducibility and sustainability. This influences buyers to favor instruments with strong compliance documentation, extended lifecycle support, and greener material choices. Vendors operating in this region must navigate diverse reimbursement and procurement rules while maintaining interoperability standards to serve multinational research consortia.

Asia-Pacific exhibits a heterogeneous mix of advanced research hubs and rapidly expanding diagnostic networks, with several markets prioritizing domestic manufacturing and indigenous innovation. The region's growth is propelled by heavy investment in genomics and biopharma R&D, yet it also presents variability in service maturity and regulatory pathways. Consequently, suppliers achieve success through flexible commercial models that combine localized manufacturing or assembly, capacity-building partnerships with local service providers, and tailored training programs to upskill laboratory personnel.

Across all regions, common cross-cutting themes include the need for robust digital support, scalable service operations, and regulatory alignment. Vendors that can adapt commercial terms to regional procurement practices and embed local support tend to outperform competitors in customer satisfaction and time-to-implementation.

How integrated platform strategies, service excellence, and ecosystem partnerships determine competitive advantage and customer retention in instrumentation

Competitive positioning in the instrumentation sector increasingly pivots on integrated offerings that combine hardware excellence with software, consumables, and lifecycle services. Leading firms differentiate through validated workflows that reduce the time from installation to actionable results, and by investing in software platforms that enable data standardization, remote monitoring, and predictive maintenance. Partnerships with reagent and consumable suppliers bolster recurring revenue while creating stickiness through locked-in workflows and certification programs for laboratory personnel.

Rising competitors are focused on niche innovations-such as ultra-high-throughput sample preparation modules, compact mass spectrometry units, or AI-driven image analysis engines-that displace legacy systems in specialized use cases. These challengers leverage agility and targeted investments to address unmet needs in single-cell profiling, spatial biology, and rapid diagnostics. Strategic alliances between instrument manufacturers and third-party software providers have become common, facilitating interoperability and accelerating time-to-results for integrated applications.

From a commercial standpoint, companies that can demonstrate measurable reductions in total operational friction-through bundled service agreements, transparent consumable pricing, and comprehensive training programs-gain preferential access to institutional purchasing channels. Furthermore, firms that align their road maps with regulatory trends and sustainability targets reinforce buyer confidence and open opportunities in public-sector procurement and large pharmaceutical partnerships. Overall, market leaders combine technological depth with scalable service delivery and ecosystem partnerships to sustain growth and protect margins in a competitive environment.

Strategic imperatives for vendors to drive resilient supply chains, modular innovation, and customer-aligned commercial models that reduce adoption friction

Leaders should prioritize a three-pronged approach that balances product innovation, supply chain resilience, and customer-centric commercial models. First, invest in modular hardware architectures and open-software ecosystems to enable rapid integration into diverse laboratory workflows. Such designs reduce customization time, facilitate third-party integrations, and allow iterative feature upgrades without wholesale hardware replacement. By emphasizing interoperability, vendors can capture a broader range of applications while supporting collaborative research environments.

Second, reinforce supply chain strategies by qualifying multiple component suppliers, pursuing regional manufacturing partnerships, and maintaining strategic component inventories for mission-critical product lines. These steps reduce exposure to tariff volatility and shorten lead times for replacement parts and consumables. In parallel, expand remote diagnostics and predictive maintenance capabilities to reduce costly on-site interventions and to improve uptime metrics for large end users.

Third, evolve commercial models to align incentives with customers through outcome-based contracts, subscription services for consumables, and hybrid service agreements that combine on-site support with remote analytics. Complement these offerings with comprehensive training and certification programs that reduce adoption friction and build long-term loyalty. Additionally, cultivate partnerships with local service providers and academic centers to enhance regional market penetration and ensure faster response times for technical support.

Taken together, these actions position suppliers to capture strategic opportunities while mitigating operational risk, enabling them to deliver both technical leadership and dependable commercial engagement.

Rigorous mixed-methods research combining practitioner interviews, technical synthesis, and expert validation to produce context-sensitive strategic insights

This research applied a mixed-methods approach combining primary qualitative interviews, secondary literature synthesis, and expert validation to ensure robust and actionable findings. Primary inputs included structured interviews with instrument managers, procurement leads, and R&D directors across academic, biotech, clinical laboratory, and pharmaceutical settings, which provided first-hand perspectives on operational pain points, procurement criteria, and service expectations. These qualitative insights were triangulated with an extensive review of peer-reviewed literature, technical white papers, regulatory guidance documents, and vendor technical specifications to validate product capabilities and deployment considerations.

Analytical methods included thematic coding of interview transcripts to surface recurring priorities, comparative assessment of product feature sets across instrument classes, and scenario analysis focused on supply chain and regulatory impacts. Regional comparisons leveraged demographic and institutional indicators to contextualize adoption dynamics. Findings were subjected to iterative expert review to refine conclusions and to ensure that recommendations align with practical constraints faced by laboratory operators and procurement groups.

Limitations include variability in procurement practices across institutions and the evolving nature of trade policy and regulatory guidance. To mitigate these constraints, the methodology emphasized cross-sector validation and sought corroboration from multiple stakeholders to improve the reliability of strategic insights presented throughout the report.

A strategic summary emphasizing platform adaptability, service depth, and supplier resilience as the foundations for sustained adoption and laboratory continuity

In conclusion, the biotechnology instrumentation sector is transitioning toward integrated, service-enabled platforms that place equal weight on hardware performance and digital ecosystems. Laboratories increasingly demand instruments that are interoperable, maintainable, and backed by predictable service models, while suppliers must reconcile innovation with supply chain resilience and regional regulatory expectations. The cumulative impact of recent trade policy adjustments has accelerated supplier diversification and regional manufacturing interest, reinforcing the need for transparent total-cost thinking in procurement conversations.

Segmentation analysis highlights that success depends on aligning product road maps to specific modality requirements and end-user workflows, whether serving high-throughput pharmaceutical discovery environments or resource-constrained academic labs. Regional dynamics necessitate tailored go-to-market approaches, blending local service presence with scalable digital support. Competitive differentiation will come from validated workflows, consumable economics, and software platforms that reduce operational friction and enable reproducible science.

For stakeholders across the ecosystem, the imperative is clear: invest in adaptable platforms, deepen service capabilities, and pursue strategic partnerships that accelerate adoption while protecting operational continuity. Those who execute on these priorities will be best positioned to capture demand and sustain long-term relationships with the laboratories that drive scientific progress.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. The integration of microfluidic lab-on-a-chip platforms for rapid point-of-care diagnostics and personalized medicine
  • 5.2. Adoption of AI-driven high-throughput screening systems to accelerate drug discovery pipelines
  • 5.3. Growth of single-cell sequencing instruments enabling deeper insights into cellular heterogeneity
  • 5.4. Emergence of portable nanopore sequencing devices democratizing genomic analysis in remote settings
  • 5.5. Utilization of CRISPR-based electrochemical biosensors for real-time pathogen detection in food safety
  • 5.6. Expansion of automated liquid handling robots to streamline repetitive sample preparation workflows in biopharma labs
  • 5.7. Implementation of label-free surface plasmon resonance imaging for multiplexed biomarker quantification
  • 5.8. Development of integrated mass spectrometry imaging instruments for spatial proteomics applications
  • 5.9. Rising demand for benchtop NMR spectroscopy systems offering high-resolution metabolomics analysis in academic labs
  • 5.10. Advances in digital PCR platforms enhancing sensitivity for rare allele detection in oncology diagnostics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biotechnology Instrumentation Market, by Instrument Type

  • 8.1. Chromatography
    • 8.1.1. FPLC
    • 8.1.2. Gas Chromatography
    • 8.1.3. HPLC
  • 8.2. Microscopy
    • 8.2.1. Confocal Microscopy
    • 8.2.2. Electron Microscopy
    • 8.2.3. Fluorescence Microscopy
  • 8.3. PCR
    • 8.3.1. dPCR
    • 8.3.2. qPCR
  • 8.4. Spectroscopy
    • 8.4.1. Mass Spectrometry
    • 8.4.2. NMR Spectroscopy
    • 8.4.3. UV-Vis Spectroscopy

9. Biotechnology Instrumentation Market, by Technology

  • 9.1. Flow Cytometry
    • 9.1.1. Cell Counting
    • 9.1.2. Cell Sorting
  • 9.2. Immunoassay
    • 9.2.1. CLIA
    • 9.2.2. ELISA
  • 9.3. Microarray
    • 9.3.1. DNA Microarray
    • 9.3.2. Protein Microarray
  • 9.4. Sequencing
    • 9.4.1. Next Generation Sequencing
    • 9.4.2. Sanger Sequencing

10. Biotechnology Instrumentation Market, by Application

  • 10.1. Diagnostics
    • 10.1.1. Clinical Diagnosis
    • 10.1.2. Point Of Care Testing
  • 10.2. Drug Discovery
    • 10.2.1. Lead Optimization
    • 10.2.2. Target Identification
  • 10.3. Genomics
    • 10.3.1. Gene Expression
    • 10.3.2. Variant Analysis
  • 10.4. Proteomics
    • 10.4.1. Protein Quantification
    • 10.4.2. Protein-Protein Interaction

11. Biotechnology Instrumentation Market, by End User

  • 11.1. Academic Research
  • 11.2. Biotechnology Companies
    • 11.2.1. Large Biotech
    • 11.2.2. Small Biotech
  • 11.3. Clinical Laboratories
  • 11.4. Contract Research Organizations
  • 11.5. Pharmaceutical
    • 11.5.1. Large Pharma
    • 11.5.2. Small Pharma

12. Biotechnology Instrumentation Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. System Integrators
    • 12.2.2. Value Added Resellers
  • 12.3. Online Sales
  • 12.4. Retail Channels

13. Biotechnology Instrumentation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biotechnology Instrumentation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biotechnology Instrumentation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Danaher Corporation
    • 16.3.3. Agilent Technologies, Inc.
    • 16.3.4. PerkinElmer, Inc.
    • 16.3.5. Bio-Rad Laboratories, Inc.
    • 16.3.6. Illumina, Inc.
    • 16.3.7. Roche Diagnostics GmbH
    • 16.3.8. Waters Corporation
    • 16.3.9. Bruker Corporation
    • 16.3.10. Shimadzu Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOTECHNOLOGY INSTRUMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FPLC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FPLC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FPLC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FPLC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FPLC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FPLC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY HPLC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY HPLC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY HPLC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY HPLC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY HPLC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY HPLC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONFOCAL MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONFOCAL MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONFOCAL MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONFOCAL MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONFOCAL MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONFOCAL MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTRON MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTRON MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTRON MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTRON MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTRON MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTRON MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DPCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DPCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DPCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DPCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DPCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DPCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY QPCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY QPCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY QPCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY QPCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NMR SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NMR SPECTROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NMR SPECTROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NMR SPECTROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NMR SPECTROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NMR SPECTROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY UV-VIS SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY UV-VIS SPECTROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY UV-VIS SPECTROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY UV-VIS SPECTROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY UV-VIS SPECTROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY UV-VIS SPECTROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL COUNTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL COUNTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL COUNTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL COUNTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL COUNTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL COUNTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL SORTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL SORTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL SORTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL SORTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL SORTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL SORTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DNA MICROARRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DNA MICROARRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DNA MICROARRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DNA MICROARRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN MICROARRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN MICROARRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN MICROARRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN MICROARRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENE EXPRESSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENE EXPRESSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENE EXPRESSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENE EXPRESSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY VARIANT ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY VARIANT ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY VARIANT ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY VARIANT ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY VARIANT ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY VARIANT ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN QUANTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN QUANTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN QUANTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN QUANTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN QUANTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN QUANTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LARGE BIOTECH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LARGE BIOTECH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LARGE BIOTECH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LARGE BIOTECH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)

TA